TNGX: Tango Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 739.38
Enterprise Value ($M) 678.21
Book Value ($M) 264.45
Book Value / Share 2.48
Price / Book 2.80
NCAV ($M) 210.27
NCAV / Share 1.97
Price / NCAV 3.52

Profitability (mra)
Return on Invested Capital (ROIC) -0.37
Return on Assets (ROA) -0.28
Return on Equity (ROE) -0.49

Liquidity (mrq)
Quick Ratio 8.23
Current Ratio 8.23

Balance Sheet (mrq) ($M)
Current Assets 352.04
Assets 406.22
Liabilities 141.77
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 36.53
Operating Income -114.17
Net Income -101.74

Cash Flow Statement (mra) ($M)
Cash From Operations -117.98
Cash from Investing 41.43
Cash from Financing 82.41

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
04-08 13G/A Southpoint Capital Advisors LP 4.90 0.00
02-13 13G/A Gilead Sciences Inc 4.80 0.00
02-09 13G/A Fmr Llc 9.60 -27.76
10-18 13D/A BCTG Holdings, LLC 15.00 7.60
10-16 13G/A EcoR1 Capital, LLC 13.10 70.30
08-21 13G Nextech Crossover I GP S.a r.l. 5.40

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-03-18 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-06-12 197,175 529,514 37.24
2024-06-11 43,792 160,889 27.22
2024-06-10 143,251 266,859 53.68
2024-06-07 115,670 259,826 44.52

(click for more detail)

Similar Companies
TENK – TenX Keane Acquisition TKNO – Alpha Teknova, Inc.
TLPH – Talphera, Inc. TRDA – Entrada Therapeutics, Inc.
TRVI – Trevi Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io